T1	Participants 51 107	rectal cancer patients with high preoperative CEA levels
T2	Participants 273 286	rectal cancer
T3	Participants 347 378	122 patients with rectal cancer
T4	Participants 473 535	Patients with preoperative CEA levels <5.0 ng/ml were excluded
T5	Participants 1586 1613	patients with rectal cancer
